The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.
The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.
What is Amplify Weight Loss Drug & Treatment stock price today?▼
The current price of THNR.BOATS is $23.94 USD — it has increased by +0% in the past 24 hours. Watch Amplify Weight Loss Drug & Treatment stock price performance more closely on the chart.
What is Amplify Weight Loss Drug & Treatment stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Amplify Weight Loss Drug & Treatment stocks are traded under the ticker THNR.BOATS.
Does Amplify Weight Loss Drug & Treatment pay dividends?▼
Yes, THNR.BOATS dividends are paid annual. The last dividend per share was 0.41 . As of today, Dividend Yield (FWD)% is 1.73%.
In which sector is Amplify Weight Loss Drug & Treatment located?▼
Amplify Weight Loss Drug & Treatment operates in the Other sector.
When did Amplify Weight Loss Drug & Treatment complete a stock split?▼
Amplify Weight Loss Drug & Treatment has not had any recent stock splits.